12
Participants
Start Date
June 30, 2012
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
IDN-6556
14 day oral treatment of the investigational caspase inhibitor drug IDN-6556 following first islet transplant at 50mg twice daily.
University of Alberta, Edmonton
Collaborators (1)
Conatus Pharmaceuticals Inc.
INDUSTRY
University of Alberta
OTHER